Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Pet DNA Testing Market Size & Growth Forecast 2026–2035, By Segments (Animal Type, Test Type, End-user, Sample Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13677| Published Date: May-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Pet DNA Testing Market size stood at USD 424.07 Million in 2025 and is predicted to grow at a 9.3% CAGR from 2026 to 2035, exceeding USD 1.03 Billion by 2035. The industry revenue for 2026 is calculated at USD 458.43 million.

Base Year Value (2025)
USD 424.07 Million
CAGR (2026-2035)
9.3%
Forecast Year Value (2035)
USD 1.03 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Pet DNA Testing Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 44.31% share, driven by high pet care spending, strong consumer awareness, veterinary integration of genetic testing, and established e-commerce channels supporting routine adoption.
  • Asia Pacific’s 10.51% CAGR is supported by rising pet ownership, urbanization, premium pet care demand, expanding digital retail access, and growing awareness of breed and health insights.

Segment Momentum

  • Dogs lead with 54.66% share due to widespread DNA testing for breed identification, lineage tracking and trait analysis, strongly integrated into adoption, breeding and routine pet care decisions.
  • Health and Wellness is the fastest-growing test type as pet owners increasingly seek preventive care-oriented genetic insights that support individualized health management and awareness of inherited risks.

Market Expansion Drivers

  • Rising pet ownership and consumer spending on pet health driving DNA testing adoption.
  • Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits.
  • Growing premiumization of pet care and personalized veterinary diagnostics services.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading players in the pet DNA testing market include Mars Petcare Inc. (United States), Zoetis Inc. (United States), Embark Veterinary, Inc. (United States), Neogen Corporation (United States), Orivet Genetic Pet Care Limited (Australia), Macrogen, Inc. (South Korea), Genetic Technologies Limited (Australia), DNA My Dog Inc. (Canada), Clinomics Inc. (South Korea).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising pet ownership and consumer spending on pet health driving DNA testing adoption

As pet ownership expands and animals are increasingly treated as long-term household companions, spending decisions are shifting from basic care toward preventive and insight-based services. In the pet DNA testing market, this translates into stronger uptake of breed identification, inherited condition screening, and trait analysis kits, especially among owners willing to invest earlier in a pet’s life. The driver works in practice by widening the addressable customer base while also raising willingness to pay for non-essential but decision-shaping health information, aiding market expansion through routine consumer purchasing rather than only veterinarian-led testing.

Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits

Lower sequencing costs and more efficient sample processing have made it commercially viable for companies to offer simpler, lower-priced test kits without removing the core value of genetic insight. This is increasing market adoption in the pet DNA testing market by reducing the cost barrier for first-time buyers and enabling direct-to-consumer distribution through e-commerce, pet retail, and subscription-based wellness channels. As accessibility improves, adoption is influenced less by specialist referral and more by convenience, with easy cheek-swab collection and digital result delivery turning pet genetics into a scalable consumer diagnostics category.

Growing premiumization of pet care and personalized veterinary diagnostics services

Premium pet care spending is pushing owners and service providers toward tools that support individualized treatment, nutrition, and wellness decisions rather than standardized care pathways. In the pet DNA testing market, that shift is strengthening market development by positioning genetic testing as part of a broader personalized care model, where results inform breed-specific risk assessment, tailored diet planning, and more targeted veterinary monitoring. The effect is especially visible in higher-value service bundles, as clinics and pet health platforms use DNA insights to differentiate offerings and deepen ongoing customer engagement rather than relying on one-time product sales alone.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising pet ownership and consumer spending on pet health driving DNA testing adoption 2.50% Low North America, Europe High Near Term
Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits 2.30% Moderate North America, Asia Pacific High Near Term
Growing premiumization of pet care and personalized veterinary diagnostics services 1.90% Moderate North America, Europe High Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
44.31% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 44.31% share of the pet DNA testing market in 2025, bolstered by a well-established pet care ecosystem, high consumer willingness to spend on companion animal health, and broad awareness of genetic screening for breed identification, trait analysis, and inherited disease risk. The region’s leadership is reinforced by the practical integration of DNA testing into routine pet ownership decisions, where consumers increasingly use test results to guide nutrition, preventive care, and breeder selection, while veterinary access and developed e-commerce channels help sustain steady test uptake.

Asia Pacific is projected to expand at a 10.51% CAGR over the forecast period, with momentum in the pet DNA testing market being impelled by rising pet ownership, increasing urbanization, and growing consumer interest in premium pet care services. Growth is accelerating as more pet owners in the region move beyond basic care toward data-driven health and wellness decisions, creating stronger adoption for genetic testing in areas such as breed verification and early health insight, particularly as access improves through digital retail platforms and expanding pet services infrastructure.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Preventive Pet Genetics

Germany is integrating pet DNA testing into preventive veterinary care and responsible breeding practices. Pet owners increasingly seek genetic insights that support early health management and informed long-term care decisions.

France 🇫🇷

Responsible Breeding Support

France utilizes pet DNA testing to strengthen responsible breeding practices and improve hereditary disease awareness. Veterinary professionals and breeders increasingly value reliable genetic screening that supports informed breeding and healthcare decisions.

Italy 🇮🇹

Personalized Veterinary Insights

Italy is seeing greater adoption of pet DNA testing as owners seek individualized health information for companion animals. Market participants focus on accessible testing services that help veterinarians tailor preventive care and breed-specific health management.

Japan 🇯🇵

Companion Animal Wellness

Japan's growing focus on companion animal health supports demand for pet DNA testing services. Providers emphasize user-friendly testing solutions that deliver breed information and actionable genetic health insights for pet owners and veterinarians.

South Korea 🇰🇷

Digital Pet Care Integration

South Korea is incorporating pet DNA testing into a broader digital pet healthcare ecosystem. Service providers combine genetic analysis with mobile health platforms and personalized wellness recommendations to improve long-term pet management.

United States 🇺🇸

Consumer Genomics Adoption

The U.S. pet DNA testing market benefits from strong consumer interest in breed identification, inherited health screening, and personalized pet care. Companies continue expanding genomic databases and veterinary partnerships to enhance testing accuracy and service offerings.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Pet DNA Testing Market Share (%), Animal Type, 2025

Dogs
Cats
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)

Dogs held the leading position in the pet DNA testing market in 2025, accounting for a 54.66% share. This leadership is underpinned by the broad use of DNA testing among dog owners for breed identification, lineage understanding, and trait assessment, all of which have direct relevance in adoption, breeding, and routine pet care decisions. The dog segment also benefits from a wider established testing base, as canine genetic testing has been more commercially visible and operationally integrated into consumer pet services than other animal categories in the pet DNA testing market.

Cats are emerging as the fastest-growing segment in the pet DNA testing market as owners show rising interest in genetic insights that go beyond basic identification and support more informed care decisions. Growth is being encouraged by increasing awareness that feline DNA testing can help clarify breed background, inherited traits, and selected health-related considerations in a category that has historically seen lower testing penetration than dogs. Relative to alternatives, the cats segment is gaining momentum because it is expanding from a smaller installed base, leaving more room for adoption as testing relevance becomes clearer to cat owners.

Test Type Segment Analysis: Breed Profile (Largest Segment) vs Health and Wellness (Fastest-Growing Segment)

Within the pet DNA testing market, Breed Profile remained the largest test type in 2025 with a 40.35% share. Its leading position is aided by strong consumer demand for straightforward answers about a pet’s breed composition, especially among mixed-breed animals where background is unknown. Breed Profile testing maintains broad appeal because it offers immediate and easily understood value to owners, helping explain physical traits and behavioral tendencies while serving as the most accessible entry point into the pet DNA testing market.

Health and Wellness is the fastest-growing test type in the pet DNA testing market because owners are increasingly looking for genetic information that can support ongoing care choices rather than one-time breed discovery alone. This segment is gaining momentum as pet care decisions become more preventive and individualized, creating stronger demand for tests that inform everyday wellness management and potential inherited risk awareness. Compared with Breed Profile, Health and Wellness is growing faster because it aligns more directly with evolving owner expectations for practical, care-oriented genetic insight.

Segment Sub-Segment Largest Segment Fastest Growing
Animal Type Dogs, Cats, Others Dogs Cats
Test Type Breed Profile, Genetic Diseases, Health and Wellness Breed Profile Health and Wellness
End-user Pet Owners, Breeders, Veterinarians Breeders Pet Owners
Sample Type Blood, Saliva, Fecal, Others Saliva Blood
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the pet DNA testing market:

1. Mars Petcare Inc. (United States)

2. Zoetis Inc. (United States)

3. Embark Veterinary Inc. (United States)

4. Neogen Corporation (United States)

5. Orivet Genetic Pet Care Limited (Australia)

6. Macrogen Inc. (South Korea)

7. Genetic Technologies Limited (Australia)

8. DNA My Dog Inc. (Canada)

9. Clinomics Inc. (South Korea)

The pet DNA testing market is expanding as pet owners increasingly seek insights into genetic traits and health predispositions. Advances in genomic analysis are improving testing accuracy and result interpretation. New service offerings are enabling more detailed breed and health profiling. The pet DNA testing market continues to evolve with rising demand for personalized pet healthcare insights.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Mars Jul-24 Mars completed the acquisition of Cerba Vet and Antagene, expanding its veterinary diagnostics and animal DNA testing capabilities in France. The acquisition enhances Mars’ position in pet genomics and veterinary diagnostics by integrating laboratory infrastructure and specialized DNA testing services for companion animal health and genetic disease identification.
The Kennel Club Feb-25 The Kennel Club introduced two DNA testing schemes targeting gangliosidosis (GM1_2 and GM2_2) in Japanese Shiba Inu dogs. The initiative supports genetic screening to identify carriers and affected dogs, strengthening breeding program accuracy and contributing to the reduction of inherited neurological diseases in purebred populations.
DNA My Dog Jan-25 DNA My Dog partnered with DreamWorks Animation’s Dog Man franchise to launch a sweepstakes integrating pet DNA testing with entertainment engagement. The initiative aims to increase consumer awareness of breed identification testing while enhancing customer acquisition through cross-industry promotional collaboration.
University of Cambridge & Wisdom Panel Aug-24 Researchers at the University of Cambridge, supported by Wisdom Panel, developed a DNA test aimed at eliminating progressive retinal atrophy in English Shepherd Dogs. The development advances genetic screening tools for inherited disease prevention and supports improved selective breeding strategies in companion animal populations.
Ancestry Sep-23 Ancestry launched its first pet DNA testing product, “Know Your Pet DNA,” expanding beyond human ancestry testing into the companion animal genomics segment. The move diversifies its product portfolio and establishes entry into the growing consumer pet genetics market.
Embark Veterinary Oct-21 Embark Veterinary launched a DNA test designed for purebred dogs, expanding its canine genetics portfolio. The product strengthens its competitive positioning in pet genomics by offering targeted breed-specific genetic insights for health, lineage, and disease risk assessment.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Pet DNA Testing Market — Custom Segments

Segment Sub-Segment
No segment data available.

Pet DNA Testing Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the pet DNA testing market?

As of 2026 the market size of pet DNA testing is valued at USD 458.43 million.

What are the growth projections for the pet DNA testing industry?

Pet DNA Testing Market size is likely to expand from USD 424.07 million in 2025 to USD 1.03 billion by 2035 posting a CAGR above 9.3% across 2026-2035.

How is rising consumer spending on pets reshaping demand in the pet DNA testing market?

Increasing pet ownership and spending on preventive care is expanding adoption of DNA testing for breed, trait, and health insights. Consumers are treating pets as long-term companions, increasing willingness to pay for early-life genetic information.

How is affordability and direct-to-consumer distribution influencing adoption of pet DNA testing kits?

Lower sequencing costs and simplified at-home kits are reducing entry barriers, enabling e-commerce and retail distribution. This shifts adoption toward convenience-driven purchases with easy sample collection and digital results rather than veterinarian-led testing pathways.

Why do dogs lead the pet DNA testing market?

Dogs lead with 54.66% share due to widespread DNA testing for breed identification, lineage tracking and trait analysis, strongly integrated into adoption, breeding and routine pet care decisions.

What is driving growth in Health and Wellness testing in pet DNA testing market?

Health and Wellness is the fastest-growing test type as pet owners increasingly seek preventive care-oriented genetic insights that support individualized health management and awareness of inherited risks.

Why does North America lead the pet DNA testing market?

North America holds 44.31% share, driven by high pet care spending, strong consumer awareness, veterinary integration of genetic testing, and established e-commerce channels supporting routine adoption.

What is driving growth in Asia Pacific’s pet DNA testing market?

Asia Pacific’s 10.51% CAGR is supported by rising pet ownership, urbanization, premium pet care demand, expanding digital retail access, and growing awareness of breed and health insights.

Which companies are driving growth in the pet DNA testing landscape?

Leading players in the pet DNA testing market include Mars Petcare Inc. (United States), Zoetis Inc. (United States), Embark Veterinary, Inc. (United States), Neogen Corporation (United States), Orivet Genetic Pet Care Limited (Australia), Macrogen, Inc. (South Korea), Genetic Technologies Limited (Australia), DNA My Dog Inc. (Canada), Clinomics Inc. (South Korea).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →